Market Overview

Denali Therapeutics Inc. (DNLI)

41.49 -1.07 (-2.51%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/16/20BTIGDowngradesNeutral
8/24/20Morgan StanleyMaintainsOverweight45.0
8/20/20HC Wainwright & Co.MaintainsBuy45.0
4/15/20Morgan StanleyMaintainsOverweight28.0
2/24/20JefferiesInitiates Coverage OnBuy35.0
2/19/20Stifel NicolausInitiates Coverage OnHold26.0
1/27/20Goldman SachsUpgradesBuy37.0
9/26/19WedbushInitiates Coverage OnNeutral19.0
9/13/19NomuraInitiates Coverage OnBuy35.0
8/09/19BTIGInitiates Coverage OnBuy30.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter